Arbeiten am Laptop. (Symbolbild)
Mittwoch, 12.04.2017 22:20 von | Aufrufe: 60

Omnicell Medication Adherence Named a 50+ Innovation Leader

Arbeiten am Laptop. (Symbolbild) © jamesteohart / iStock / Getty Images Plus / Getty Images http://www.gettyimages.de/

PR Newswire

MOUNTAIN VIEW, Calif., April 12, 2017 /PRNewswire/ -- Omnicell's (NASDAQ: OMCL) Medication Adherence Division was announced today as one of the healthcare industry's 50+ Innovation Leaders, an AARP initiative administered by MedCity News to recognize entrepreneurs, companies, and ideas behind innovative new products and services for Americans aged 50 and older.

The winners of the inaugural 50+ Innovation Leaders program were revealed today during the AARP Innovation@50+ Live Pitch event by representatives of MedCity News and AARP.

"AARP works to empower people to choose how they live as they age," said Jeffrey Makowka, AARP's director of market innovation. "We are pleased to join MedCity News in showcasing entrepreneurs who are driving change and improvements in the healthcare industry for the more than 100 million Americans aged 50 and older. We congratulate the remarkable winners who have been recognized by their peers for their innovation leadership."

"As the population of patients and caregivers over 50 continues to grow in the coming years, supporting care in a way that doesn't interfere with daily activities is imperative," said Rob Seim, president, Global Automation and Medication Adherence at Omnicell. "Not taking medications as prescribed represents one of the biggest threats to the health of these individuals. We're honored that our medication adherence solutions have been recognized by AARP and MedCity News, and look forward to continuing our support of medication safety for patients both at home, and in the acute care setting."

In late 2016, MedCity News and AARP issued a call for nominations for entrepreneurs, investors, companies and nonprofit collaborations. Determined by a reader vote, the winners include leaders and companies offering healthcare delivery, medication management and smart wearables.

The full list of winners can be seen at medcitynews.com/50-plus-innovation-leaders/.


ARIVA.DE Börsen-Geflüster

Kurse

27,86 $
+2,69%
Omnicell Chart

About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit www.omnicell.com.

About AARP
AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering Americans 50 and older to choose how they live as they age. With nearly 38 million members and offices in every state, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, AARP works to strengthen communities and advocate for what matters most to families with a focus on health security, financial stability and personal fulfillment. AARP also works for individuals in the marketplace by sparking new solutions and allowing carefully chosen, high-quality products and services to carry the AARP name. As a trusted source for news and information, AARP produces the world's largest circulation publications, AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media.

About MedCity News
MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what's next and what matters with a mix of breaking news and analysis on startups and established industry leaders, personalities, policies and the most important deals. Learn more at www.medcitynews.com or follow @medcitynews on social media.

OMCL-G

Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicell-medication-adherence-named-a-50-innovation-leader-300438858.html

SOURCE Omnicell, Inc.

Werbung

Mehr Nachrichten zur Omnicell Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News